Complement C5 is cleaved into C5a, a potent inflammatory mediator, and C5b, which starts assembly of the membrane attack complex. That makes C5 a major target in complement and therapeutic antibody research.
Athens Bioscience supplies human C5 purified from plasma, frozen at ≥95% purity by SDS-PAGE. It is used for C5 immunoassay development, antibody screening and characterization, and complement pathway research.
Complement C5, a glycoprotein composed of α (115 kDa) and β (75 kDa) chains, serves as the linchpin of complement-mediated immunity. Cleaved by C5 convertases into C5a (potent anaphylatoxin) and C5b (initiator of membrane attack complex/MAC), it bridges inflammatory signaling and pathogen lysis. C5a drives chemotaxis, leukocyte activation, and vascular permeability via C5aR1/C5aR2 receptors, while C5b-9 (MAC) induces microbial cytolysis.
C5 deficiency increases susceptibility to recurrent pyogenic infections (e.g., Neisseria) and Leiner’s disease. Elevated C5a correlates with rheumatoid arthritis, Guillain-Barré syndrome, and chemotherapy-induced neuropathy.
Common uses include complement and immune system research, IVD assay standards, calibrators and controls.
Not a hazardous substance or mixture.
12 - Non Combustible Liquids
Complement C5 is cleaved into C5a, a potent inflammatory mediator, and C5b, which starts assembly of the membrane attack complex. That makes C5 a major target in complement and therapeutic antibody research.
Athens Bioscience supplies human C5 purified from plasma, frozen at ≥95% purity by SDS-PAGE. It is used for C5 immunoassay development, antibody screening and characterization, and complement pathway research.